The Future of SCLC: Next Steps, Treatments, and Progress - 2022 Program: LCVL

Advancing targeted therapies for SCLCПодробнее

Assessing the Impact of Therapeutic Advances in SCLCПодробнее

Recent Progress in the Treatment of SCLCПодробнее

Facilitating Progress in the Treatment of SCLCПодробнее

Treating Limited and Advanced Stage SCLC - 2022 Program: LCVLПодробнее

Recent Advances in SCLC Treatment - 2022 Program: LCVLПодробнее

Innovations in Immunotherapy: Advancing care in SCLCПодробнее

Chemoimmunotherapy in SCLC - 2022 Program: LCVLПодробнее

A New Era Has Begun in the Treatment of SCLC: Navigating Novel Therapeutic Options and StrategiesПодробнее

Dr. Forster on Next Steps With Lurbinectedin in SCLCПодробнее

Simon Heeke, PhD: Biomarker Development in SCLC to Enable Personalized Clinical TrialsПодробнее

Integrating New Options Into the SCLC Treatment Arsenal to Improve Patient OutcomesПодробнее

Next steps for the CONVERT trial in LS-SCLCПодробнее

Toward Better Outcomes in SCLC: Immunotherapy Has Changed the Game, but Where Do We Go Next?Подробнее

Making the Most of Treatment Advances in SCLCПодробнее

Exploring the latest advances in first-line treatment of ES-SCLCПодробнее